Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Treasury Shares (2022 - 2024)

Maxcyte (MXCT) has disclosed Treasury Shares for 3 consecutive years, with $1.7 million as the latest value for Q4 2024.

  • On a quarterly basis, Treasury Shares rose 31.47% to $1.7 million in Q4 2024 year-over-year; TTM through Dec 2024 was $1.7 million, a 31.47% increase, with the full-year FY2024 number at $1.7 million, up 31.47% from a year prior.
  • Treasury Shares was $1.7 million for Q4 2024 at Maxcyte, up from $1.3 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $1.7 million in Q4 2024 to a low of $643600.0 in Q4 2022.
  • A 3-year average of $1.2 million and a median of $1.3 million in 2023 define the central range for Treasury Shares.
  • Peak YoY movement for Treasury Shares: soared 101.4% in 2023, then soared 31.47% in 2024.
  • Maxcyte's Treasury Shares stood at $643600.0 in 2022, then surged by 101.4% to $1.3 million in 2023, then soared by 31.47% to $1.7 million in 2024.
  • Per Business Quant, the three most recent readings for MXCT's Treasury Shares are $1.7 million (Q4 2024), $1.3 million (Q4 2023), and $643600.0 (Q4 2022).